CAS number: 77326-96-6

General information about the Flunisolide Hemihydrate active pharmaceutical ingredient

Flunisolide Hemihydrate as active pharmaceutical ingredient (API) is a corticosteroid or steroid, class of glucocorticoid with anti-inflammatory actions. Flunisolide Hemihydrate API used for treatment for allergic rhinitis and the maintenance treatment of asthma. Flunisolide Hemihydrate can be administered with metered-dose inhaler for the treatment of asthma and as nasal spray for treating allergic rhinitis.

Axplora manufactures Flunisolide Hemihydrate API

Flunisolide Hemihydrate API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Flunisolide Hemihydrate API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Flunisolide Hemihydrate API is commercially available as micronized grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Flunisolide Hemihydrate API.
  • Therapeutic area Respiratory
  • Monograph USP
  • Available grade Micronized
  • Regulatory documentation EU DMF
    US DMF#
  • Produced in GRO